Bank of America
TVTX icon

Bank of America’s Travere Therapeutics TVTX Stock Holding History

Bank of America’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40M Sell
1,345,111
-505,244
-27% -$15.1M ﹤0.01% 1771
2025
Q4 		$70.7M Buy
1,850,355
+451,425
+32% +$14.7M 0.01% 1321
2025
Q3 		$33.4M Sell
1,398,930
-222,463
-14% -$4.18M ﹤0.01% 2109
2025
Q2 		$24M Buy
1,621,393
+675,487
+71% +$11.2M ﹤0.01% 2381
2025
Q1 		$17M Sell
945,906
-385,482
-29% -$7.82M ﹤0.01% 2624
2024
Q4 		$23.2M Sell
1,331,388
-383,232
-22% -$6.78M ﹤0.01% 2157
2024
Q3 		$24M Sell
1,714,620
-164,334
-9% -$1.71M ﹤0.01% 2227
2024
Q2 		$15.4M Buy
1,878,954
+169,321
+10% +$1.14M ﹤0.01% 2502
2024
Q1 		$13.2M Buy
1,709,633
+88,166
+5% +$744K ﹤0.01% 2687
2023
Q4 		$14.6M Buy
1,621,467
+406,241
+33% +$2.96M ﹤0.01% 2458
2023
Q3 		$10.9M Sell
1,215,226
-134,277
-10% -$1.89M ﹤0.01% 2638
2023
Q2 		$20.7M Buy
1,349,503
+531,678
+65% +$9.67M ﹤0.01% 2006
2023
Q1 		$18.4M Buy
817,825
+261,887
+47% +$5.57M ﹤0.01% 2205
2022
Q4 		$11.7M Buy
555,938
+122,520
+28% +$2.6M ﹤0.01% 2531
2022
Q3 		$10.7M Sell
433,418
-90,879
-17% -$2.35M ﹤0.01% 2559
2022
Q2 		$12.7M Sell
524,297
-74,580
-12% -$1.88M ﹤0.01% 2443
2022
Q1 		$15.4M Buy
598,877
+87,507
+17% +$2.32M ﹤0.01% 2418
2021
Q4 		$15.9M Sell
511,370
-444,060
-46% -$12.5M ﹤0.01% 2446
2021
Q3 		$23.2M Sell
955,430
-717,055
-43% -$13.2M ﹤0.01% 2043
2021
Q2 		$24.4M Sell
1,672,485
-763,586
-31% -$15.1M ﹤0.01% 1963
2021
Q1 		$60.8M Buy
2,436,071
+37,438
+2% +$1.03M 0.01% 1161
2020
Q4 		$65.4M Buy
2,398,633
+984,414
+70% +$23M 0.01% 1009
2020
Q3 		$26.1M Buy
1,414,219
+6,011
+0.4% +$117K ﹤0.01% 1492
2020
Q2 		$28.7M Sell
1,408,208
-30,890
-2% -$492K ﹤0.01% 1360
2020
Q1 		$21M Buy
1,439,098
+175,546
+14% +$2.64M ﹤0.01% 1469
2019
Q4 		$17.9M Buy
1,263,552
+107,193
+9% +$1.37M ﹤0.01% 1981
2019
Q3 		$13.4M Buy
1,156,359
+36,588
+3% +$605K ﹤0.01% 2210
2019
Q2 		$22.5M Sell
1,119,771
-365,492
-25% -$7.22M ﹤0.01% 1770
2019
Q1 		$33.6M Buy
1,485,263
+261,558
+21% +$5.78M 0.01% 1413
2018
Q4 		$27.7M Buy
1,223,705
+652,895
+114% +$16.2M ﹤0.01% 1432
2018
Q3 		$16.4M Buy
570,810
+402,020
+238% +$11.5M ﹤0.01% 2015
2018
Q2 		$4.6M Buy
168,790
+25,911
+18% +$690K ﹤0.01% 3244
2018
Q1 		$3.19M Sell
142,879
-18,705
-12% -$445K ﹤0.01% 3488
2017
Q4 		$3.4M Sell
161,584
-4,462
-3% -$102K ﹤0.01% 3484
2017
Q3 		$4.13M Buy
166,046
+59,048
+55% +$1.3M ﹤0.01% 3352
2017
Q2 		$2.07M Buy
106,998
+9,578
+10% +$174K ﹤0.01% 3850
2017
Q1 		$1.8M Buy
97,420
+49,277
+102% +$964K ﹤0.01% 3962
2016
Q4 		$912K Buy
48,143
+22,382
+87% +$458K ﹤0.01% 4410
2016
Q3 		$576K Buy
25,761
+4,237
+20% +$80.7K ﹤0.01% 4524
2016
Q2 		$383K Buy
21,524
+11,597
+117% +$188K ﹤0.01% 4830
2016
Q1 		$135K Sell
9,927
-4,844
-33% -$73.5K ﹤0.01% 5342
2015
Q4 		$285K Buy
14,771
+8,485
+135% +$170K ﹤0.01% 5153
2015
Q3 		$128K Sell
6,286
-13,444
-68% -$398K ﹤0.01% 5559
2015
Q2 		$654K Buy
+19,730
New +$540K ﹤0.01% 4487
2014
Q4 		– Sell
-6,198
Closed -$56K – 7966
2014
Q3 		$56K Sell
6,198
-3,502
-36% -$41.2K ﹤0.01% 6428
2014
Q2 		$114K Buy
+9,700
New +$131K ﹤0.01% 6030

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America's TVTX Position: Q1 2026 in Review

Bank of America reduced its Travere Therapeutics (TVTX) stake by 27% in Q1 2026, selling an estimated $15.1M and leaving 1,345,111 shares worth $40M. The position accounts for ﹤0.01% of the portfolio, ranked #1771.

Bank of America first reported a position in TVTX in Q2 2014 and has held it in 46 quarters since. The position peaked at $70.7M in Q4 2025. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Bank of America held 1,345,111 shares of Travere Therapeutics worth $40M as of Q1 2026.
  • Bank of America sold 505,244 Travere Therapeutics shares in Q1 2026, an estimated $15.1M.
  • Travere Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1771 holding.
  • Bank of America first reported a position in Travere Therapeutics in Q2 2014 and has held it in 46 quarters since.
  • Bank of America's Travere Therapeutics position peaked at $70.7M in Q4 2025.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.